Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Capital City Bank Group

28.1% sales growth and 12.48% return on equity

Capital City Bank Group, Inc. operates as the financial holding company for Capital City Bank that provides a range of banking and banking-related services to individual and corporate clients.

Capital City Bank Group’s sales growth this year is anticipated to be 36.3% and a negative 2.3% for next year.

Year-on-year quarterly revenue growth grew by 49.5%, now sitting on 188.94M for the twelve trailing months.

Capital City Bank Group’s sales growth for the next quarter is 28.1%. The company’s growth estimates for the present quarter and the next is a negative 2% and 76%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.48%.

Volatility

Capital City Bank Group’s last day, last week, and last month’s average volatility was a positive 1.61%, a negative 0.81%, and a positive 0.32%, respectively.

Capital City Bank Group’s last day, last week, and last month’s high and low average amplitude percentage was 8.50%, 5.01%, and 3.80%, respectively.

Capital City Bank Group’s Stock Yearly Top and Bottom Value

Capital City Bank Group’s stock is valued at $24.64 at 10:22 EST, way under its 52-week high of $30.95 and way higher than its 52-week low of $15.61.

Capital City Bank Group’s Moving Average

Capital City Bank Group’s worth is higher than its 50-day moving average of $23.82 and way higher than its 200-day moving average of $21.03.

2. Horizon Therapeutics Public Limited Company

34.3% sales growth and 29.59% return on equity

Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally.

Horizon Therapeutics Public Limited Company’s sales growth this year is expected to be 64.1% and 27.3% for next year.

Year-on-year quarterly revenue growth grew by 89.7%, now sitting on 1.82B for the twelve trailing months.

Horizon Therapeutics Public Limited Company’s sales growth for the next quarter is 34.3%. The company’s growth estimates for the ongoing quarter and the next is 82.1% and 70%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.59%.

Volatility

Horizon Therapeutics Public Limited Company’s last day, last week, and last month’s average volatility was a positive 1.70%, a negative 2.59%, and a negative 0.16%, respectively.

Horizon Therapeutics Public Limited Company’s last day, last week, and last month’s high and low average amplitude percentage was 2.93%, 3.59%, and 3.89%, respectively.

Horizon Therapeutics Public Limited Company’s Stock Yearly Top and Bottom Value

Horizon Therapeutics Public Limited Company’s stock is valued at $68.14 at 10:22 EST, way under its 52-week high of $86.67 and way higher than its 52-week low of $23.81.

Horizon Therapeutics Public Limited Company’s Moving Average

Horizon Therapeutics Public Limited Company’s worth is under its 50-day moving average of $72.13 and below its 200-day moving average of $69.08.

3. ResMed Inc.

5.1% sales growth and 28.35% return on equity

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases.

ResMed Inc.’s sales growth this year is expected to be 6.4% and 8.2% for next year.

Year-on-year quarterly revenue growth grew by 10.4%, now sitting on 3.03B for the twelve trailing months.

ResMed Inc.’s sales growth for the next quarter is 5.1%. The company’s growth estimates for the ongoing quarter and the next is 4.1% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.35%.

Volatility

ResMed Inc.’s last day, last week, and last month’s average volatility was 2.21%, 1.33%, and 0.17%, respectively.

ResMed Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.23%, 2.06%, and 1.80%, respectively.

ResMed Inc.’s Stock Yearly Top and Bottom Value

ResMed Inc.’s stock is valued at $218.45 at 10:22 EST, under its 52-week high of $224.24 and way higher than its 52-week low of $108.85.

ResMed Inc.’s Moving Average

ResMed Inc.’s value is above its 50-day moving average of $210.55 and way higher than its 200-day moving average of $188.05.

4. eHealth, Inc.

50.7% sales growth and 12.33% return on equity

eHealth, Inc. provides private health insurance exchange services to individuals, families, and small businesses in the United States and China.

eHealth, Inc.’s sales growth this year is expected to be 30.2% and 28.3% for next year.

Year-on-year quarterly revenue growth grew by 34.9%, now sitting on 591.21M for the twelve trailing months.

eHealth, Inc.’s sales growth for the next quarter is 50.7%. The company’s growth estimates for the present quarter and the next is a negative 2.2% and negative -20.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.33%.

Volatility

eHealth, Inc.’s last day, last week, and last month’s average volatility was a positive 1.44%, a positive 0.51%, and a negative 0.15%, respectively.

eHealth, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.60%, 3.16%, and 4.41%, respectively.

eHealth, Inc.’s Stock Yearly Top and Bottom Value

eHealth, Inc.’s stock is valued at $71.96 at 10:22 EST, way under its 52-week high of $152.19 and way above its 52-week low of $60.40.

eHealth, Inc.’s Moving Average

eHealth, Inc.’s value is below its 50-day moving average of $73.60 and way under its 200-day moving average of $82.43.

5. Niu Technologies

138% sales growth and 20.55% return on equity

Niu Technologies designs, manufactures, and sells smart electric-scooters in the People's Republic of China.

Niu Technologies’s sales growth this year is expected to be 22.8% and 75.5% for next year.

Year-on-year quarterly revenue growth grew by 36.7%, now sitting on N/A for the twelve trailing months.

Niu Technologies’s sales growth for the next quarter is 138%. The company’s growth estimates for the present quarter and the next is a negative 38.5% and 250%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.55%.

Volatility

Niu Technologies’s last day, last week, and last month’s average volatility was a negative 4.06%, a negative 0.31%, and a negative 0.76%, respectively.

Niu Technologies’s last day, last week, and last month’s high and low average amplitude percentage was 7.96%, 6.73%, and 6.82%, respectively.

Niu Technologies’s Stock Yearly Top and Bottom Value

Niu Technologies’s stock is valued at $28.31 at 10:22 EST, way under its 52-week high of $37.44 and way above its 52-week low of $6.08.

Niu Technologies’s Moving Average

Niu Technologies’s worth is under its 50-day moving average of $30.34 and way higher than its 200-day moving average of $23.27.

6. Turtle Beach Corporation

42.1% sales growth and 62.37% return on equity

Turtle Beach Corporation operates as an audio technology company.

Turtle Beach Corporation’s sales growth this year is expected to be 41.5% and a negative 2.7% for next year.

Year-on-year quarterly revenue growth grew by 140.8%, now sitting on 328.94M for the twelve trailing months.

Turtle Beach Corporation’s sales growth for the next quarter is 42.1%. The company’s growth estimates for the ongoing quarter and the next is a negative 41.3% and 95.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 62.37%.

Volatility

Turtle Beach Corporation’s last day, last week, and last month’s average volatility was 1.75%, 1.08%, and 1.76%, respectively.

Turtle Beach Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 5.42%, 5.90%, and 6.09%, respectively.

Turtle Beach Corporation’s Stock Yearly Top and Bottom Value

Turtle Beach Corporation’s stock is valued at $26.10 at 10:22 EST, below its 52-week high of $26.48 and way above its 52-week low of $4.05.

Turtle Beach Corporation’s Moving Average

Turtle Beach Corporation’s value is way higher than its 50-day moving average of $20.09 and way higher than its 200-day moving average of $18.07.

LEAVE A REPLY

Please enter your comment!
Please enter your name here